UC San Diego Launches New Nonalcoholic Fatty Liver Disease Research Center

Roughly one-quarter of all Americans – an estimated 100 million adults and children – have nonalcoholic fatty liver disease (NAFLD), a chronic condition that can lead to cirrhosis, liver cancer and liver failure. Combining a diverse array of basic science, biomarkers, imaging and clinical efforts, University of California, San Diego School of Medicine has launched a new NAFLD Research Center to better understand the disease and develop treatments where none currently exist.

“We already have a lot of depth and breadth in the study and treatment of NAFLD and associated conditions at UC San Diego,” said Rohit Loomba, MD, professor of medicine in the Division of Gastroenterology and director of the new center. … Read the full story from the UC San Diego Newsroom


Rohit Loomba, MDNAFLD Research Center director Rohit Loomba, MD, MHSc, is Professor of Clinical Medicine and Associate Director of Clinical Research in the Division of Gastroenterology and Hepatology.

He is a clinical and translational physician-scientist who focuses his work on chronic liver diseases with particular attention to nonalcoholic fatty liver disease (NAFLD). He is an internationally recognized expert in translational research and innovative clinical trial design in NAFLD and nonalcoholic steatohepatitis (NASH) and hepatic fibrosis.

He directs the NAFLD Clinic at UC San Diego Medical Center.

Dr. Loomba became a member of the Division of Gastroenterology faculty in 2009, when he graduated from the UC San Diego Gastroenterology Fellowship Program. He received his clinical and research training in advanced hepatology at the National Institutes of Health.

He holds an adjunct faculty appointment in the UC San Diego Division of Epidemiology, Department of Family Medicine and Public Health at UC San Diego.

Four Department of Medicine Faculty Members Are on 2015 Thomson Reuters Highly Cited Researchers List

Dr. William Sandborn

William Sandborn, MD

Four UC San Diego Department of Medicine researchers are among the most influential researchers in the world, according to the 2015 Thomson Reuters Highly Cited Researchers list.

They are , William Sandborn, MDDon W. Cleveland, PhD, Lewis J. Rubin, MD, and Sergei L. Kosakovsky Pond, PhD.

Dr. Don W. Cleveland

Don W. Cleveland, PhD

Dr. Sandborn is Professor and Chief of the Division of Gastroenterology & Hepatology.

Dr. Cleveland is Chair of the Department of Cellular and Molecular Medicine and Distinguished Professor of Medicine, Cellular and Molecular Medicine, and Neurosciences.

Sergei L. Kosakovsky Pond, PhD

Sergei L. Kosakovsky Pond, PhD

Dr. Pond, Associate Professor of Medicine, is a specialist in infectious disease with a focus on developing software models of evolving pathogens such as HIV and hepatitis C virus.

Dr. Rubin, whose research addresses pulmonary vascular disease and pulmonary arterial hypertension, is Professor of Medicine, Emeritus, in the Division of Pulmonary, Critical Care & Sleep Medicine.

Lewis Rubin, MD

Lewis Rubin, MD

With 165 faculty members on the latest edition of the list, the UC System ranks first in the world on the list of highly cited researchers.

Each year, Thomson Reuters uses citation analysis to identify the world’s most influential contemporary scientists. The 2015 list, encompassing publications from 2003 to 2013, contains more than 3,100 names.

More on the UC System’s achievement from the UC Office of the President

See the names of all UC System faculty members on the list

More about the list and the methodology from Thomson Reuters

View a searchable database of the researchers